CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 11 - 20 of 841
Study Number Lead Group Study Title CIRB Study Status
NRG-CC007CD NRG Increasing the Dose of Survivorship Care Planning in Prostate Cancer Survivors Who Receive Androgen Deprivation Therapy Cancer Prevention and Control CIRB Available to Open
S1823 SWOG A Prospective Observational Cohort Study To Assess miRNA 371 For Outcome Prediction in Patients With Newly Diagnosed Germ Cell Tumors Cancer Prevention and Control CIRB Available to Open
URCC-16092 NCORP-University of Rochester Cancer Center Phase II Study of Exercise and Low-Dose Ibuprofen for Cognitive Impairment in Colorectal Cancer Patients Receiving Chemotherapy Cancer Prevention and Control CIRB Available to Open
UAZ2017-09-02 CLO-University of Arizona Clinical Study of Avmacol® for Detoxification of Tobacco Carcinogens in Heavy Smokers Cancer Prevention and Control CIRB Available to Open
EAQ172 ECOG-ACRIN Optimizing Immunosuppression for Steroid- Refractory Anti-PD-1/PD-L1 Pneumonitis Cancer Prevention and Control CIRB Available to Open
A211601 Alliance Evaluation of Mammographic Breast Density Effect of Aspirin: A companion study to Alliance Study A011502 Cancer Prevention and Control CIRB Available to Open
WF-97116 NCORP-Wake Forest University A Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil in Chemotherapy Exposed Breast Cancer Survivors with Cognitive Impairment Cancer Prevention and Control CIRB Available to Open
A221504 Alliance A Randomized; Double-Blind; Placebo-Controlled Pilot Study of an Oral; Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer (Adenocarcinoma) Cancer Prevention and Control CIRB Available to Open
UAZ2015-05-02 CLO-University of Arizona M4OC-Prevent: Metformin for Oral Cancer Prevention Cancer Prevention and Control CIRB Available to Open
MAY2016-07-01 CLO-Mayo Clinic Phase II Trial of Weekly Erlotinib Dosing to Reduce Duodenal Polyp Burden Associated with Familial Adenomatous Polyposis Cancer Prevention and Control CIRB Available to Open
Displaying 11 - 20 of 841